| ［1］ |
Sung H，Ferlay J，Siegel RL，et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin，2021，71（3）: 209-249.
|
| ［2］ |
Xia C，Dong X，Li H，et al. Cancer statistics in China and United States，2022: profiles，trends，and determinants［J］. Chin Med J，2022，135（5）: 584-590.
|
| ［3］ |
Carrerette FB，Rodeiro DB，Filho R T F，et al. Randomized controlled trial comparing open anterograde anatomic radical retropubic prostatectomy with retrograde technique［J］. Asian J Urol，2023，10（2）: 151-157.
|
| ［4］ |
覃小燕，彭鹏. 多参数磁共振成像在前列腺癌主动监测中的应用研究进展［J］. 江苏大学学报（医学版），2023，33（5）: 386-390，443.Qin XY，Peng P. Research progress of multi-parameter magnetic resonance imaging in active monitoring of prostate cancer［J］.J Jiangsu Univ Med Ed，2023，33（5）: 386-390，443.
|
| ［5］ |
陈佳俊，胡广漠，徐昕煜，等. 根治性前列腺切除术与近距离放疗治疗局限性前列腺癌的预后研究［J］. 现代泌尿生殖肿瘤杂志，2024，16（4）: 208-215.Chen JJ，Hu GM，Xu XY，et al. Prognostic study on radical prostatectomy versus brachytherapy for localized prostate cancer［J］.J Contemp Urol Reprod Oncol，2024，16（4）:208-215.
|
| ［6］ |
Pooli A，Salmasi A，Johnson DC，et al. Positive surgical margins at radical prostatectomy in the United States: institutional variations and predictive factors［J］. Urol Oncol，2020，38（1）: 1.e17-1.e11.e23.
|
| ［7］ |
Ozbek A，Ozbek R，Duvarci M，et al. Does the distance of the tumor from the surgical margin affect biochemical recurrence in patients with pathological organ-confined prostate cancer？［J］. Turk Patoloji Derg，2021，37（3）: 233-238.
|
| ［8］ |
贺大千，王昕凝，王琨翔，等. 根治性前列腺切除术后患者生化复发的贝叶斯预测模型的构建及临床价值［J］. 精准医学杂志，2022，37（3）: 252-256.He DQ，Wang XN，Wang KX，et al. Construction and clinical value of Bayesian prediction model for biochemical recurrence after radical prostatectomy［J］. J Precis Med，2022，37（3）: 252-256.
|
| ［9］ |
Gandi C，Totaro A，Bientinesi R，et al. A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training［J］. J Rob Surg，2022，16（6）: 1451-1461.
|
| ［10］ |
穆靖军，马增妮，曹晓明，等. 前列腺癌根治术后切缘阳性的危险因素［J］. 现代泌尿外科杂志，2022，27（6）: 475-479，498.Mu JJ，Ma ZN，Cao XM，et al. Risk factors of positive surgical margin after radical prostatectomy［J］. J Mod Urol，2022，27（6）: 475-479，498.
|
| ［11］ |
Kawase M，Ebara S，Tatenuma T，et al. Clinical factors associated with biochemical recurrence of prostate cancer with seminal vesicle invasion followed by robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan （the MSUG94 group）［J］. J Robot Surg，2023，17（4）: 1609-1617.
|
| ［12］ |
Preisser F，Heinze A，S Abrams-Pompe R，et al. Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with nonorgan-confined prostate cancer［J］.Prostate，2022，82（9）: 949-956.
|
| ［13］ |
Su SH，Chang YH，Huang LK，et al. Clinical predictors for biochemical failure in patients with positive surgical margin after robotic-assisted radical prostatectomy［J］. Tumori，2022，108（3）: 270-277.
|
| ［14］ |
Yang CW，Wang HH，Hassouna MF，et al. Prediction of a positive surgical margin and biochemical recurrence after robot-assisted radical prostatectomy［J］. Sci Rep，2021，11（1）: 14329.
|
| ［15］ |
Sasaki T，Ebara S，Tatenuma T，et al. Prognostic differences among the positive surgical margin locations following robot-assisted radical prostatectomy in a large Japanese cohort （the MSUG94 group）［J］.Jpn J Clin Oncol，2023，53（5）: 443-451.
|
| ［16］ |
Godoy G，Tareen BU，Lepor H. Site of positive surgical margins influences biochemical recurrence after radical prostatectomy［J］.BJU Int，2009，104（11）: 1610-1614.
|
| ［17］ |
Ogawa S，Hasegawa A，Makabe S，et al. Impacts of neoadjuvant hormonal therapy prior to robot-assisted radical prostatectomy on postoperative hormonal- and sexual-related quality of life - assessment by patient-reported questionnaire［J］. Res Rep Urol，2022，14: 39-48.
|
| ［18］ |
Martini A，Marqueen KE，Falagario UG，et al. Estimated costs associated with radiation therapy for positive surgical margins during radical prostatectomy［J］. JAMA Netw Open，2020，3（3）: e201913.
|
| ［19］ |
O'Connor-Cordova MA，Macías AGO，Sancen-Herrera JP，et al.Surgical and functional outcomes of Retzius-sparing robotic-assisted radical prostatectomy versus conventional robotic-assisted radical prostatectomy in patients with biopsy-confirmed prostate cancer. Are outcomes worth it？ Systematic review and meta-analysis［J］. Prostate，2023，83（15）: 1395-1414.
|
| ［20］ |
Wang Y，Chen X，Liu K，et al. Predictive factors for gleason score upgrading in patients with prostate cancer after radical prostatectomy: a systematic review and meta-analysis［J］. Urol Int，2023，107（5）: 460-479.
|
| ［21］ |
Kim M，Yoo D，Pyo J，et al. Clinicopathological significances of positive surgical resection margin after radical prostatectomy for prostatic cancers: a meta-analysis［J］. Medicina，2022，58（9）: 1251.
|
| ［22］ |
Liu LT，Cui D，Wang M，et al. Clinicopathological significance of 114 cases with positive surgical margin in radical prostatectomy specimens［J］. Chin J Pathol，2022，51（7）: 627-633.
|
| ［23］ |
Li H，Chang X，Du Y. Perineural invasion detected in prostate biopsy is a predictor of positive surgical margin of radical prostatectomy specimen: a meta-analysis［J］. Andrologia，2022，54（5）: e14395.
|
| ［24］ |
Farzat M，Weib P，Sukhanov I，et al. Effect of neoadjuvant hormonal therapy on the postoperative course for patients undergoing robotassisted radical prostatectomy［J］. J Clin Med，2023，12（9）: 3053.
|
| ［25］ |
Yossepowitch O，Briganti A，Eastham JA，et al. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update［J］. Eur Urol，2014，65（2）: 303-313.
|
| ［26］ |
Oufattole J，Dey T，D'Amico AV，et al. Cribriform morphology is associated with higher risk of biochemical recurrence after radical prostatectomy in patients with grade group 5 prostate cancer［J］.Histopathology，2023，82（7）: 1089-1097.
|
| ［27］ |
van der Slot MA，Remmers S，Kweldam CF，et al. Biopsy prostate cancer perineural invasion and tumour load are associated with positive posterolateral margins at radical prostatectomy: implications for planning of nerve-sparing surgery［J］. Histopathology，2023，83（3）: 348-356.
|
| ［28］ |
Tafuri A，Cerruto MA，Antonelli A. Neoadjuvant strategies before radical prostatectomy for high risk prostate cancer in the era of new hormonal agents［J］. Curr Drug Targets，2021，22（1）: 68-76.
|
| ［29］ |
Devos G，Devlies W，De Meerleer G，et al. Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer［J］.Nat Rev Urol，2021，18（12）: 739-762.
|
| ［30］ |
Bravi CA，Tin A，Vertosick E，et al. The impact of experience on the risk of surgical margins and biochemical recurrence after robotassisted radical prostatectomy: a learning curve study［J］. J Urol，2019，202（1）: 108-113.
|
| ［31］ |
Sivaraman A，Sanchez-Salas R，Prapotnich D，et al. Learning curve of minimally invasive radical prostatectomy: comprehensive evaluation and cumulative summation analysis of oncological outcomes［J］. Urol Oncol，2017，35（4）: 149.e1-149149.e6.
|
| ［32］ |
Bravi CA，Dell'Oglio P，Mazzone E，et al. The surgical learning curve for biochemical recurrence after robot-assisted radical prostatectomy［J］. Eur Urol Oncol，2023，6（4）: 414-421.
|
| ［33］ |
Galfano A，Secco S，Olivero A，et al. The spread of retzius-sparing robotic prostatectomy: an update after 10 years［J］. Curr Opin Urol，2023，33（5）: 367-374.
|
| ［34］ |
Rosenberg JE，Jung JH，Edgerton Z，et al. Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer［J］. Cochrane Database Syst Rev，2020，8（8）: CD013641.
|
| ［35］ |
Moussa M，Abou Chakra M，Peyromaure M，et al. Comparison of oncological，surgical，and functional outcomes between radical retropubic and radical perineal prostatectomy: a multi-institutional study［J］. Urologia，2023，90（1）: 89-99.
|
| ［36］ |
Soeterik TFW，van Melick HHE，Dijksman LM，et al. Nerve sparing during robot-assisted radical prostatectomy increases the risk of ipsilateral positive surgical margins［J］. J Urol，2020，204（1）: 91-95.
|
| ［37］ |
Kyriazis I，Spinos T，Tsaturyan A，et al. Different nerve-sparing techniques during radical prostatectomy and their impact on functional outcomes［J］. Cancers，2022，14（7）: 1601.
|
| ［38］ |
Shikanov S，Woo J，Al-Ahmadie H，et al. Extrafascial versus interfascial nerve-sparing technique for robotic-assisted laparoscopic prostatectomy: comparison of functional outcomes and positive surgical margins characteristics［J］. Urology，2009，74（3）: 611-616.
|
| ［39］ |
Takahara K，Sumitomo M，Fukaya K，et al. Clinical and oncological outcomes of robot-assisted radical prostatectomy with nerve sparing vs. non-nerve sparing for high-risk prostate cancer cases［J］. Oncol Lett，2019，18（4）: 3896-3902.
|
| ［40］ |
Dinneen E，Haider A，Allen C，et al. NeuroSAFE robot-assisted laparoscopic prostatectomy versus standard robot-assisted laparoscopic prostatectomy for men with localised prostate cancer（NeuroSAFE PROOF）: protocol for a randomised controlled feasibility study［J］. BMJ Open，2019，9（6）: e028132.
|
| ［41］ |
Tappero S，Vecchio E，Palagonia E，et al. Retzius-sparing robotassisted radical prostatectomy after previous trans-urethral resection of the prostate: assessment of functional and oncological outcomes［J］.Eur J Surg Oncol，2023，49（8）: 1524-1535.
|
| ［42］ |
Mottet N，van den Bergh RCN，Briers E，et al. EAU-EANM-ESTROESUR-SIOG guidelines on prostate cancer-2020 update. part 1:screening，diagnosis，and local treatment with curative intent［J］. Eur Urol，2021，79（2）: 243-262.
|
| ［43］ |
Pisansky TM，Thompson IM，Valicenti RK，et al. Adjuvant and salvage radiotherapy after prostatectomy: ASTRO/AUA guideline amendment 2018-2019［J］. J Urol，2019，202（3）: 533-538.
|
| ［44］ |
薛蔚，董樑，钱宏阳，等. 前列腺癌新辅助治疗与辅助治疗的现状及进展［J］. 北京大学学报（医学版），2023，55（5）: 775-780.Xue W，Dong L，Qian HY，et al. The current status and progress of neoadjuvant therapy and adjuvant therapy for prostate cancer ［J］. J Peking Univ （Medical Edition），2023，55 （5）: 775-780.
|
| ［45］ |
Le Guevelou J，Magne N，Counago F，et al. Stereotactic body radiation therapy after radical prostatectomy: current status and future directions［J］. World J Urol，2023，41（11）: 3333-3344.
|
| ［46］ |
Westhofen T，Buchner A，Schlenker B，et al. Timing of radiotherapy after radical prostatectomy: effects on health-related quality of life［J］.J Urol，2021，206（5）: 1192-1203.
|
| ［47］ |
张俊彪，王志华. 局限性前列腺癌的治疗新进展［J］. 现代泌尿生殖肿瘤杂志，2023，15（4）: 193-196.Zhang JB，Wang ZH. New progress in the treatment of localized prostate cancer［J］. J Contemp Urol Reprod Oncol，2023，15（4）: 193-196.
|
| ［48］ |
Carrie C，Magné N，Burban-Provost P，et al. Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer （GETUG-AFU 16）: a 112-month follow-up of a phase 3，randomised trial［J］. Lancet Oncol，2019，20（12）: 1740-1749.
|
| ［49］ |
Shipley WU，Seiferheld W，Lukka HR，et al. Radiation with or without antiandrogen therapy in recurrent prostate cancer［J］. N Engl J Med，2017，376（5）: 417-428.
|
| ［50］ |
Tran PT，Lowe K，Tsai HL，et al. Phase II randomized study of salvage radiation therapy plus enzalutamide or placebo for high-risk prostatespecific antigen recurrent prostate cancer after radical prostatectomy:the SALV-ENZA trial［J］. J Clin Oncol，2023，41（6）: 1307-1317.
|